ElizabethAnneMaherMD

Oncology • Dallas, TX

Associate Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Maher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maher's full profile

Already have an account?

Office
5323 Harry Hines Blvd
Stop 7200
Dallas, TX 75390
Phone+1 214-645-5905

Fax+1 214-645-5999

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
McGill University Faculty of MedicineClass of 1993

Certifications & Licensure

TX State Medical License 2006 - 2026
MA State Medical License 1997 - 2007

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas Start of enrollment: 2011 Apr 01
Terminated
Phase 2
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection Start of enrollment: 2009 Aug 01
Recruiting
Not Applicable
High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors Start of enrollment: 2009 Aug 28
Completed

Publications & Presentations

PubMed

16 citations
Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution.
Hongyi Zhang, Xuexin Yu, Jianfeng Ye, Huiyu Li, Jing Hu
Cancer Cell. 2023-10-09
17 citations
Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment.
Qi Cai, Xiaoqing Li, Hejian Xiong, Hanwen Fan, Xiaofei Gao
Nature Communications. 2023-08-15
11 citations
Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas.
Eric J Hsu, Jamie Thomas, Elizabeth A Maher, Michael Youssef, Robert D Timmerman
Discover. Oncology. 2022-11-15

Press Mentions

New Test Uncovers Metabolic Vulnerabilities in Kidney CancerAugust 29th, 2018
Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
North Texan Overcomes the Odds, Graduates from Dream SchoolJune 16th, 2017
Join now to see all

Grant Support

Defining The Metabolic Phenotype Of Low Grade Gliomas In VivoNational Cancer Institute2012
Glioma Metabolism In Patients In VivoNational Center For Research Resources2011
Genotype And Metabolic Phenotype In GlioblastomaNational Center For Research Resources2010
Genotype And Metabolic Phenotype In GlioblastomaNational Institute Of Neurological Disorders And Stroke2009–2010
Metabolism In Human GliomasNational Center For Research Resources2009
Genetic Pathways Toward GliomagenesisNational Cancer Institute1999–2003